Literature DB >> 20477679

Mechanisms of leukocyte trafficking in allergic diseases: insights into new therapies targeting chemokines and chemokine receptors.

Masako Toda1, Takao Nakamura, Masaharu Ohbayashi, Yoshifumi Ikeda, Maria Dawson, Cho Cho Aye, Dai Miyazaki, Santa Jeremy Ono.   

Abstract

Marked inflammatory infiltration by activated leukocytes is a characteristic feature of allergic diseases. Elucidation of the mechanisms of leukocyte trafficking in allergic diseases would identify targets to establish novel anti-inflammatory strategies for treatment of these diseases. Leukocyte trafficking is controlled by tissue-specific expression of chemokines and chemokine receptor expression on the leukocyte surface. Here, we review the role of chemokines and their receptors in leukocyte trafficking to inflammatory sites in allergic diseases and discuss therapeutic strategies targeting chemokine networks for treatment of these diseases.

Entities:  

Year:  2007        PMID: 20477679     DOI: 10.1586/1744666X.3.3.351

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  3 in total

1.  Evidence that formation of vimentin mitogen-activated protein kinase (MAPK) complex mediates mast cell activation following FcεRI/CC chemokine receptor 1 cross-talk.

Authors:  Masako Toda; Chuan-Hui Kuo; Satty K Borman; Ricardo Micheler Richardson; Akihito Inoko; Masaki Inagaki; Andrea Collins; Klaus Schneider; Santa Jeremy Ono
Journal:  J Biol Chem       Date:  2012-05-21       Impact factor: 5.157

Review 2.  New twists to an old story: novel concepts in the pathogenesis of allergic eye disease.

Authors:  Daniel R Saban; Virginia Calder; Chuan-Hui Kuo; Nancy J Reyes; Darlene A Dartt; Santa J Ono; Jerry Y Niederkorn
Journal:  Curr Eye Res       Date:  2013-01-02       Impact factor: 2.424

3.  Role of CCL7 in Type I Hypersensitivity Reactions in Murine Experimental Allergic Conjunctivitis.

Authors:  Chuan-Hui Kuo; Andrea M Collins; Douglas R Boettner; YanFen Yang; Santa J Ono
Journal:  J Immunol       Date:  2016-12-12       Impact factor: 5.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.